Sorbonne Venture
Austral Dx
Austral Dx is a French startup developing, based on the research of Mathias Fink and the Langevin Institute, the first contactless auscultation device powered by artificial intelligence that fully automates the cardiopulmonary auscultation process. This new device will accelerate and improve the diagnosis and monitoring of heart and lung diseases.
Austral Dx maps vibrations in the lung and heart areas to detect potential pathologies using innovative imaging technology based on aerial ultrasound.
Activité
Research and development of diagnostic technologies, manufacturing of medical equipment
Secteur
Diagnostic, Santé
Métier
Venture Deeptech
Statut
In portfolio
Date d'acquisition
2024
Montant de l'investissement
100K